相关实验视频
Updated: Jan 29, 2026

06:41
Veno-Venous Extracorporeal Membrane Oxygenation in a Mouse
Published on: October 24, 2018
13.0K
不同的低激活凝血时间针对患者在体外膜氧化管理期间的抗凝血方案:一个回顾性队列研究
Fengnian Gu1, Ming Zhang1, Zhuo Zhang1
1Harbin Medical University, Harbin, Heilongjiang, China.
Frontiers in medicine
|January 28, 2026
概括
在体外膜氧化 (ECMO) 期间保持特定的激活凝固时间 (ACT) 水平至关重要. 这项研究在ECMO患者中没有发现增加氧化器问题,出血或凝块的风险,不同的ACT目标低.
科学领域:
- 心血管医学 心血管医学
- 临界护理医学 临界护理医学
- 血液学 血液学 血液学
背景情况:
- 对于接受体外膜氧化 (ECMO) 的患者来说,有效的抗凝药是必不可少的,以防止严重的并发症.
- 在ECMO期间激活凝血时间 (ACT) 的最佳目标范围仍然是正在进行的临床研究领域.
研究的目的:
- 评估不同低激活凝血时间 (ACT) 目标范围对接受ECMO的患者临床结果的影响.
- 为了确定不同的低ACT目标是否会影响氧化器故障,出血事件或血栓栓塞并发症的发生率.
主要方法:
- 一项回顾性队列研究包括148名接受ECMO支持的患者.
- 根据患者的ACT水平,患者被分为三组:低 (<160秒),中等 (160-180秒) 和高 (>180秒).
- 评估的关键结果包括ECMO氧化器变化,出血事件和血栓塞栓并发症.
主要成果:
- 在低,中和高ACT组的氧化剂变化率中没有观察到统计学上显著的差异 (p=0.39).
- 在三个ACT组中,出血事件的发生率没有显著差异 (p=0.45).
- 同样,血栓栓塞事件的发生率在ACT组之间没有显著差异 (p=0.68).
结论:
- 在ECMO患者中实施不同的低ACT标抗凝方案似乎不会增加氧化器失效,出血或血栓栓塞的风险.
- 这些发现表明,临床医生在选择ECMO管理较低范围内的ACT目标时可能具有灵活性.
- 建议进行进一步的前性研究,以验证这些发现,并完善ECMO的最佳抗凝策略.
相关概念视频
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
2.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
2.3K
Clot Retraction and Fibrinolysis
8.8K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.8K
Appendicitis-II: Diagnostic Studies and Management
547
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
547
Acute Pyelonephritis II: Diagnostic Studies and Management
387
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
387
Anticoagulant Drugs: Low-Molecular-Weight Heparins
1.8K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
1.8K
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
214
Hemoperfusion and hemofiltration are critical techniques in medical treatments to eliminate accumulated drugs, metabolites, and electrolytes from the bloodstream. These methods are particularly vital in cases of accidental poisoning and drug overdose.Hemoperfusion involves passing blood through an adsorbent material to remove unwanted substances. The main adsorbents used in hemoperfusion include activated charcoal and Amberlite resins. Activated charcoal can adsorb both polar and nonpolar...
214

